
|Articles|January 26, 2004
FDA delays mandate on aluminum labeling in TPNs
FDA delays the date of effectiveness of its labeling requirements related to aluminum toxicity in total parenteral nutrition solutions
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
3
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
4
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
5


























